178 related articles for article (PubMed ID: 16176017)
1. Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem.
Rahman NU; Yuen KH; Woei WJ
Pharm Dev Technol; 2005; 10(3):371-9. PubMed ID: 16176017
[TBL] [Abstract][Full Text] [Related]
2. Novel orally swallowable IntelliCap(®) device to quantify regional drug absorption in human GI tract using diltiazem as model drug.
Becker D; Zhang J; Heimbach T; Penland RC; Wanke C; Shimizu J; Kulmatycki K
AAPS PharmSciTech; 2014 Dec; 15(6):1490-7. PubMed ID: 25023947
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the gastrointestinal transit and in vivo drug release of isosorbide-5-nitrate pellets.
Fischer W; Boertz A; Davis SS; Khosla R; Cawello W; Sandrock K; Cordes G
Pharm Res; 1987 Dec; 4(6):480-5. PubMed ID: 3508560
[TBL] [Abstract][Full Text] [Related]
4. The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs.
Basit AW; Newton JM; Short MD; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2001 Aug; 18(8):1146-50. PubMed ID: 11587486
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem.
Li SP; Felt RG; Di Paolo LC; Huang MY; Williams RO
Pharm Res; 1995 Sep; 12(9):1338-42. PubMed ID: 8570532
[TBL] [Abstract][Full Text] [Related]
6. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets.
Abrahamsson B; Alpsten M; Hugosson M; Jonsson UE; Sundgren M; Svenheden A; Tölli J
Pharm Res; 1993 May; 10(5):709-14. PubMed ID: 8321836
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an enteric-coated naproxen pellet formulation.
Hardy JG; Lamont GL; Evans DF; Haga AK; Gamst ON
Aliment Pharmacol Ther; 1991 Feb; 5(1):69-75. PubMed ID: 1932483
[TBL] [Abstract][Full Text] [Related]
8. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).
Wilding IR; Hardy JG; Davis SS; Melia CD; Evans DF; Short AH; Sparrow RA; Yeh KC
Clin Neuropharmacol; 1991 Aug; 14(4):305-21. PubMed ID: 1913698
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
[TBL] [Abstract][Full Text] [Related]
11. Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats.
Amekyeh H; Billa N; Yuen KH; Lim SC
AAPS PharmSciTech; 2016 Oct; 17(5):1060-6. PubMed ID: 26511938
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of multiparticulate sustained-release diltiazem preparations in dogs.
Murata K; Noda K
J Pharm Sci; 1994 Jan; 83(1):38-41. PubMed ID: 8138907
[TBL] [Abstract][Full Text] [Related]
13. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
Stevens HN; Speakman M
Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
[TBL] [Abstract][Full Text] [Related]
14. Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers.
Levein NG; Thörn SE; Wattwil M
Eur J Anaesthesiol; 1999 Apr; 16(4):246-50. PubMed ID: 10234494
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.
Hodges LA; Sime KA; Creech LA; Connolly SM; Barclay ST; Kwon MC; Jeon BJ; Shim SM; Wang HS; Stevens HN; Park JS
Int J Pharm; 2013 Sep; 454(1):41-6. PubMed ID: 23834829
[TBL] [Abstract][Full Text] [Related]
16. A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats.
Amekyeh H; Billa N; Yuen KH; Chin SL
AAPS PharmSciTech; 2015 Aug; 16(4):871-7. PubMed ID: 25588365
[TBL] [Abstract][Full Text] [Related]
17. The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride.
McClelland GA; Sutton SC; Engle K; Zentner GM
Pharm Res; 1991 Jan; 8(1):88-92. PubMed ID: 2014214
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of extended-release formulations of calcium antagonists and of amlodipine in subjects with different gastrointestinal transit times.
Zimmermann T; Laufen H; Yeates R; Scharpf F; Riedel KD; Schumacher T
J Clin Pharmacol; 1999 Oct; 39(10):1021-31. PubMed ID: 10516936
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog.
Mizuta H; Kawazoe Y; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2810-3. PubMed ID: 1981694
[TBL] [Abstract][Full Text] [Related]
20. The use of formulation technology to assess regional gastrointestinal drug absorption in humans.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Eur J Pharm Sci; 2004 Feb; 21(2-3):179-89. PubMed ID: 14757489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
